Avapritinib versus Placebo in Indolent Systemic MastocytosisJason Gotlib, Robyn M. Scherber, Iván Álvarez‐Twöse et al.|NEJM Evidence|2023Cited by 74
Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosisRoberta Zanotti, Peter Valent, Massimiliano Bonifacio et al.|Leukemia|2021Cited by 55
Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM RegistryVanessa E. Kennedy, Hanneke Oude Elberink, Cecelia Perkins et al.|Blood Advances|2022Cited by 39
Quality of Life in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Improves after Minimal Residual Disease-Guided Treatment with Ibrutinib Plus VenetoclaxLaura Eurelings, Mark‐David Levin, Emelie Curovic Rotbain et al.|Blood|2024Cited by 1